The elevated serum S100A8/A9 during acute myocardial infarction is not of cardiac myocyte origin

Chang-Qing Du1, Lin Yang, Jie Han

  • 1Institute of Cardiology, the First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qing Chun Road, Hangzhou, Zhejiang 310003, People's Republic of China.

Inflammation
|September 3, 2011
PubMed

Insights

Increased S100A8/A9 proteins after acute myocardial infarction (AMI) do not originate from cardiac myocytes. Studies show ischemia and hypoxia activate NF-kappaB but do not alter S100A8/A9 expression in heart cells.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Inflammation Research

Background:

  • Elevated circulating S100A8/A9 levels are observed in patients post-acute myocardial infarction (AMI).
  • The cellular origin of these proteins, specifically cardiac myocytes, following ischemic events remains undetermined.

Purpose of the Study:

  • To investigate whether ischemia induces S100A8 and S100A9 expression in cardiac myocytes.
  • To determine if cardiac myocytes contribute to the circulating S100A8/A9 pool after myocardial infarction.

Main Methods:

  • Western blot analysis and quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR).
  • Experiments utilized isolated rat hearts (spontaneously hypertensive and Wistar-Kyoto) subjected to global ischemia.
  • Neonatal rat cardiac myocytes were exposed to hypoxic conditions.

Main Results:

  • Myocardial S100A8 and S100A9 protein and mRNA levels did not increase following ischemia in either rat model.
  • S100A8/A9 protein levels remained unchanged in hypoxic neonatal cardiac myocytes.
  • NF-kappaB activation was observed in response to ischemia and hypoxia in a time-dependent manner.

Conclusions:

  • Cardiac myocytes are not the source of elevated serum S100A8/A9 concentrations observed after AMI.
  • While ischemia/hypoxia activate NF-kappaB in cardiac cells, they do not stimulate S100A8/A9 production within these cells.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...